TSPOAP1 and hepatocellular carcinoma: As for BZRAP1‐AS1, Wang et al.14found that its knockout in hepatocellular carcinoma cells reduced the proliferation, migration, and angiogenesis of human umbilical vein endothelial cells, thereby retarding cancer progression.